China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBPO | HALO | CRSP | ||
| Company | China Biologic Produ | Halozyme Therapeutic | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 118.01 | 38.40 | 53.16 | ||
| High | 120.05 | 40.00 | 55.97 | ||
| Low | 117.27 | 38.29 | 52.74 | ||
| Last | 119.99 | 39.30 | 53.81 | ||
| Change | +1.98 | +1.20 | +0.82 | ||
| % Change | +1.68% | +3.15% | +1.55% | ||
| Volume | 390,900 | 1,031,800 | 1,342,800 | ||
| 20-Day Average Volume | 113,045 | 877,235 | 1,319,035 | ||
| Previous Close | 118.01 | 38.10 | 52.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 118.25 | 38.98 | 58.15 | ||
| 20-Day Raw Stochastic | 97.99% | 41.64% | 7.44% | ||
| 20-Day Relative Strength | 65.93% | 51.01% | 33.29% | ||
| Weighted Alpha | +12.44 | +20.64 | -22.25 | ||
| Today's Opinion | 56% Buy | 40% Buy | 40% Sell | ||
| Previous Opinion | 8% Sell | 8% Buy | 40% Sell | ||
| Last Month's Opinion | 24% Buy | 56% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.45% since 04/13/21 | +0.46% since 04/24/24 | -3.31% since 04/24/24 | ||
| Low | 117.27 on 04/20/21 | 37.97 on 04/30/24 | 52.73 on 04/30/24 | ||
| High | 120.05 on 04/20/21 | 40.00 on 05/01/24 | 55.97 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +1.82% since 03/19/21 | -4.89% since 04/01/24 | -21.08% since 04/01/24 | ||
| Low | 117.06 on 03/23/21 | 37.73 on 04/19/24 | 52.73 on 04/30/24 | ||
| High | 120.05 on 04/20/21 | 41.50 on 04/05/24 | 67.25 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | +1.27% since 01/20/21 | +14.71% since 02/01/24 | -16.79% since 02/01/24 | ||
| Low | 115.69 on 01/27/21 | 33.15 on 02/05/24 | 52.73 on 04/30/24 | ||
| High | 120.05 on 04/20/21 | 42.64 on 03/13/24 | 91.10 on 02/22/24 | ||
| 6-Month | |||||
| %Chg | +5.61% since 10/20/20 | +17.28% since 11/01/23 | +22.99% since 11/01/23 | ||
| Low | 112.29 on 10/26/20 | 33.15 on 02/05/24 | 44.04 on 11/02/23 | ||
| High | 120.05 on 04/20/21 | 42.82 on 12/14/23 | 91.10 on 02/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,722,806 | 4,840,757 | 4,497,951 | ||
| Shares Outstanding, K | 39,360 | 127,054 | 84,883 | ||
| Annual Sales | 524,370,000 | 829,250,000 | 371,210,000 | ||
| Annual Net Income | 152,290,000 | 281,590,000 | -153,610,000 | ||
| Last Quarter Sales | 112,100,000 | 230,040,000 | 201,210,000 | ||
| Last Quarter Net Income | 23,680,000 | 85,390,000 | 89,350,000 | ||
| 60-Month Beta | 0.42 | 1.25 | 1.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.82 on 02/20/24 | 1.10 on 02/21/24 | ||
| Latest Earnings Date | 05/19/21 | 05/07/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 29.28 | 15.20 | 0.00 | ||